Healthcare provider profile · identity verified

Jeffrey L. Lukas, MD

Family Practice · EAST CHINA, MI · NPI 1346239365

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	453	130
Levothyroxine Sodium	Levothyroxine Sodium	405	97
Omeprazole	Omeprazole	326	81
Simvastatin	Simvastatin	318	80
Amlodipine Besylate	Amlodipine Besylate	311	84
Alprazolam	Alprazolam	307	67
Metformin Hcl	Metformin Hcl	302	77
Losartan Potassium	Losartan Potassium	281	78
Lisinopril	Lisinopril	263	70
Hydrochlorothiazide	Hydrochlorothiazide	236	69
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	236	38
Gabapentin	Gabapentin	224	45
Metoprolol Succinate	Metoprolol Succinate	189	52
Tamsulosin Hcl	Tamsulosin Hcl	170	49
Potassium Chloride	Potassium Chloride	153	43
Metoprolol Tartrate	Metoprolol Tartrate	152	40
Montelukast Sodium	Montelukast Sodium	148	41
Furosemide	Furosemide	134	41
Atenolol	Atenolol	127	36
Pantoprazole Sodium	Pantoprazole Sodium	123	33
Tramadol Hcl	Tramadol Hcl	116	30
Rosuvastatin Calcium	Rosuvastatin Calcium	115	31
Albuterol Sulfate Hfa	Albuterol Sulfate	111	30
Glimepiride	Glimepiride	110	29
Meloxicam	Meloxicam	92	31
Methylprednisolone	Methylprednisolone	92	79
Sertraline Hcl	Sertraline Hcl	92	25
Eliquis	Apixaban	89	23
Cephalexin	Cephalexin	83	67
Jardiance	Empagliflozin	82	21
Clonazepam	Clonazepam	80	12
Allopurinol	Allopurinol	77	20
Ibuprofen	Ibuprofen	77	19
Citalopram Hbr	Citalopram Hydrobromide	74	21
Fluticasone Propionate	Fluticasone Propionate	73	31
Pravastatin Sodium	Pravastatin Sodium	67	21
Prednisone	Prednisone	65	44
Duloxetine Hcl	Duloxetine Hcl	63	18
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	63	14
Clopidogrel	Clopidogrel Bisulfate	62	18
Famotidine	Famotidine	61	25
Ropinirole Hcl	Ropinirole Hcl	61	suppressed
Azithromycin	Azithromycin	58	45
Meclizine Hcl	Meclizine Hcl	58	25
Fluoxetine Hcl	Fluoxetine Hcl	55	11
Trazodone Hcl	Trazodone Hcl	54	17
Carvedilol	Carvedilol	53	18
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	53	29
Synthroid	Levothyroxine Sodium	51	15
Benazepril Hcl	Benazepril Hcl	50	12
Amitriptyline Hcl	Amitriptyline Hcl	48	14
Pregabalin	Pregabalin	48	12
Doxycycline Hyclate	Doxycycline Hyclate	47	38
Enalapril Maleate	Enalapril Maleate	47	13
Januvia	Sitagliptin Phosphate	46	12
Bupropion Xl	Bupropion Hcl	45	suppressed
Alendronate Sodium	Alendronate Sodium	44	12
Spironolactone	Spironolactone	44	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	43	suppressed
Lansoprazole	Lansoprazole	42	12
Tizanidine Hcl	Tizanidine Hcl	42	27
Azelastine Hcl	Azelastine Hcl	41	19
Verapamil Er	Verapamil Hcl	41	suppressed
Xarelto	Rivaroxaban	41	13
Hydralazine Hcl	Hydralazine Hcl	39	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	39	suppressed
Nifedipine Er	Nifedipine	38	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	35	11
Pioglitazone Hcl	Pioglitazone Hcl	35	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	34	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	33	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	33	suppressed
Irbesartan	Irbesartan	33	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	32	26
Paroxetine Hcl	Paroxetine Hcl	32	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	32	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	30	suppressed
Memantine Hcl	Memantine Hcl	30	suppressed
Baclofen	Baclofen	29	11
Oxybutynin Chloride	Oxybutynin Chloride	29	suppressed
Chlorthalidone	Chlorthalidone	28	suppressed
Ezetimibe	Ezetimibe	28	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	27	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Lorazepam	Lorazepam	27	suppressed
Metformin Hcl Er	Metformin Hcl	27	suppressed
Farxiga	Dapagliflozin Propanediol	26	suppressed
Naproxen	Naproxen	26	suppressed
Ondansetron Odt	Ondansetron	26	suppressed
Warfarin Sodium	Warfarin Sodium	26	suppressed
Levetiracetam	Levetiracetam	25	suppressed
Celecoxib	Celecoxib	24	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	24	suppressed
Finasteride	Finasteride	23	suppressed
Ramipril	Ramipril	23	suppressed
Donepezil Hcl	Donepezil Hcl	21	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	21	suppressed
Myrbetriq	Mirabegron	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	12
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	suppressed
Clobetasol Propionate	Clobetasol Propionate	20	11
Clonidine Hcl	Clonidine Hcl	20	suppressed
Methocarbamol	Methocarbamol	20	suppressed
Propranolol Hcl	Propranolol Hcl	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	15
Bumetanide	Bumetanide	19	suppressed
Hydrocortisone	Hydrocortisone	19	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	18	suppressed
Diclofenac Sodium	Diclofenac Sodium	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	18	suppressed
Trospium Chloride	Trospium Chloride	18	suppressed
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	17	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Cefuroxime	Cefuroxime Axetil	15	suppressed
Cimetidine	Cimetidine	15	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Ipratropium Bromide	Ipratropium Bromide	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Anastrozole	Anastrozole	14	suppressed
Glipizide Er	Glipizide	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Ozempic	Semaglutide	14	suppressed
Repaglinide	Repaglinide	14	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Loperamide	Loperamide Hcl	13	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Mupirocin	Mupirocin	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Torsemide	Torsemide	13	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Roflumilast	Roflumilast	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Ammonium Lactate	Ammonium Lactate	11	suppressed
Aspirin-Dipyridamole Er	Aspirin/Dipyridamole	11	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error